Over 10 million people worldwide have Parkinson's disease (PD). 89% of people with PD have a speech problem (hypokinetic dysarthria) where people speak so softly they cannot be understood and can no longer communicate and stay socially active. SpeechVive is a wearable device which gives IMMEDIATE, NOTICEABLE, and LASTING improvement to over 75% of people who use the device. SpeechVive was developed at Purdue University and has published clinical trials demonstrating efficacy. SpeechVive has been on the market in the U.S. for 2 1/2 years, has revenue of over $300,000, 80% of revenue is through the VA medical centers. SpeechVive has sold over 300 devices to date.,Over 10 million people worldwide have Parkinson's disease (PD). 89% of people with PD have a speech problem (hypokinetic dysarthria) where people speak so softly they cannot be understood and can no longer communicate and stay socially active. SpeechVive is a wearable device which gives IMMEDIATE, NOTICEABLE, and LASTING improvement to over 75% of people who use the device. SpeechVive was developed at Purdue University and has published clinical trials demonstrating efficacy. SpeechVive has been on the market in the U.S. for 2 1/2 years, has revenue of over $300,000, 80% of revenue is through the VA medical centers. SpeechVive has sold over 300 devices to date.